AllSquare Wealth Management LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
AllSquare Wealth Management LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$14,026
-69.4%
309
-56.4%
0.01%
-70.0%
Q2 2023$45,823
+42.9%
7090.0%0.03%
+42.9%
Q1 2023$32,068
+11.3%
7090.0%0.02%
+5.0%
Q4 2022$28,821
-37.3%
7090.0%0.02%
-39.4%
Q3 2022$46,000
+7.0%
7090.0%0.03%
+13.8%
Q2 2022$43,000
-4.4%
7090.0%0.03%
+7.4%
Q1 2022$45,000
-16.7%
7090.0%0.03%
-12.9%
Q4 2021$54,000
-33.3%
709
-2.6%
0.03%
-35.4%
Q3 2021$81,000
-31.4%
7280.0%0.05%
-30.4%
Q2 2021$118,000
+15.7%
728
-12.7%
0.07%
+9.5%
Q1 2021$102,000
-11.3%
834
+11.5%
0.06%
-18.2%
Q4 2020$115,000
+101.8%
748
+9.5%
0.08%
+87.8%
Q3 2020$57,000
+14.0%
6830.0%0.04%
+7.9%
Q2 2020$50,000
+212.5%
683
+78.3%
0.04%
+171.4%
Q1 2020$16,000
-30.4%
3830.0%0.01%
-12.5%
Q4 2019$23,000
+15.0%
383
-20.7%
0.02%
+6.7%
Q3 2019$20,000
-4.8%
483
+6.2%
0.02%
-6.2%
Q2 2019$21,000
+31.2%
4550.0%0.02%
+33.3%
Q1 2019$16,000
+1500.0%
455
+1416.7%
0.01%
+1100.0%
Q4 2018$1,0000.0%300.0%0.00%0.0%
Q3 2018$1,000
-50.0%
300.0%0.00%
-50.0%
Q2 2018$2,000
+100.0%
300.0%0.00%
+100.0%
Q1 2018$1,0000.0%30
-50.0%
0.00%0.0%
Q4 2017$1,0000.0%600.0%0.00%0.0%
Q3 2017$1,000600.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders